Relaxin/insulin-like family peptide receptor 2

Relaxin/insulin-like family peptide receptor 2, also known as RXFP2, is a human G-protein coupled receptor.[5]

RXFP2
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesRXFP2, GPR106, GREAT, INSL3R, LGR8, LGR8.1, RXFPR2, Relaxin/insulin-like family peptide receptor 2, relaxin/insulin like family peptide receptor 2, relaxin family peptide receptor 2
External IDsOMIM: 606655 MGI: 2153463 HomoloGene: 15402 GeneCards: RXFP2
Gene location (Human)
Chr.Chromosome 13 (human)[1]
Band13q13.1Start31,739,526 bp[1]
End31,803,389 bp[1]
Orthologs
SpeciesHumanMouse
Entrez

122042

140498

Ensembl

ENSG00000133105

ENSMUSG00000053368

UniProt

Q8WXD0

Q91ZZ5

RefSeq (mRNA)

NM_001166058
NM_130806

NM_001289564
NM_001289566
NM_080468

RefSeq (protein)

NP_001159530
NP_570718

NP_001276493
NP_001276495
NP_536716

Location (UCSC)Chr 13: 31.74 – 31.8 MbChr 5: 150.02 – 150.08 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

The receptors for glycoprotein hormones such as follicle-stimulating hormone (FSH; see MIM 136530) and thyroid-stimulating hormone (TSH; see MIM 188540) are G protein-coupled, 7-transmembrane receptors (GPCRs) with large N-terminal extracellular domains. Leucine-rich repeat (LRR)-containing GPCRs (LGRs) form a subgroup of the GPCR superfamily.[supplied by OMIM][5]

See also

References
  1. GRCh38: Ensembl release 89: ENSG00000133105 - Ensembl, May 2017
  2. GRCm38: Ensembl release 89: ENSMUSG00000053368 - Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. "Entrez Gene: RXFP2 relaxin/insulin-like family peptide receptor 2".

Further reading
  • Bathgate RA, Ivell R, Sanborn BM, et al. (2005). "Receptors for relaxin family peptides". Ann. N. Y. Acad. Sci. 1041: 61–76. doi:10.1196/annals.1282.010. PMID 15956688.
  • Bathgate RA, Ivell R, Sanborn BM, et al. (2006). "International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides". Pharmacol. Rev. 58 (1): 7–31. doi:10.1124/pr.58.1.9. PMID 16507880.
  • Hsu SY, Nakabayashi K, Nishi S, et al. (2002). "Activation of orphan receptors by the hormone relaxin". Science. 295 (5555): 671–4. doi:10.1126/science.1065654. PMID 11809971.
  • Kumagai J, Hsu SY, Matsumi H, et al. (2002). "INSL3/Leydig insulin-like peptide activates the LGR8 receptor important in testis descent". J. Biol. Chem. 277 (35): 31283–6. doi:10.1074/jbc.C200398200. PMID 12114498.
  • Gorlov IP, Kamat A, Bogatcheva NV, et al. (2003). "Mutations of the GREAT gene cause cryptorchidism". Hum. Mol. Genet. 11 (19): 2309–18. doi:10.1093/hmg/11.19.2309. PMID 12217959.
  • Sudo S, Kumagai J, Nishi S, et al. (2003). "H3 relaxin is a specific ligand for LGR7 and activates the receptor by interacting with both the ectodomain and the exoloop 2". J. Biol. Chem. 278 (10): 7855–62. doi:10.1074/jbc.M212457200. PMID 12506116.
  • Ferlin A, Simonato M, Bartoloni L, et al. (2003). "The INSL3-LGR8/GREAT ligand-receptor pair in human cryptorchidism". J. Clin. Endocrinol. Metab. 88 (9): 4273–9. doi:10.1210/jc.2003-030359. PMID 12970298.
  • Roh J, Virtanen H, Kumagai J, et al. (2004). "Lack of LGR8 gene mutation in Finnish patients with a family history of cryptorchidism". Reprod. Biomed. Online. 7 (4): 400–6. doi:10.1016/S1472-6483(10)61883-4. PMID 14656401.
  • Vinci G, Anjot MN, Trivin C, et al. (2005). "An analysis of the genetic factors involved in testicular descent in a cohort of 14 male patients with anorchia". J. Clin. Endocrinol. Metab. 89 (12): 6282–5. doi:10.1210/jc.2004-0891. PMID 15579790.
  • Büllesbach EE, Schwabe C (2005). "LGR8 signal activation by the relaxin-like factor". J. Biol. Chem. 280 (15): 14586–90. doi:10.1074/jbc.M414443200. PMID 15708846.
  • Muda M, He C, Martini PG, et al. (2005). "Splice variants of the relaxin and INSL3 receptors reveal unanticipated molecular complexity". Mol. Hum. Reprod. 11 (8): 591–600. doi:10.1093/molehr/gah205. PMID 16051677.
  • Rosengren KJ, Zhang S, Lin F, et al. (2006). "Solution structure and characterization of the LGR8 receptor binding surface of insulin-like peptide 3". J. Biol. Chem. 281 (38): 28287–95. doi:10.1074/jbc.M603829200. PMID 16867980.
  • Bogatcheva NV, Ferlin A, Feng S, et al. (2007). "T222P mutation of the insulin-like 3 hormone receptor LGR8 is associated with testicular maldescent and hinders receptor expression on the cell surface membrane". Am. J. Physiol. Endocrinol. Metab. 292 (1): E138–44. doi:10.1152/ajpendo.00228.2006. PMID 16926383.
  • Scott DJ, Layfield S, Yan Y, et al. (2007). "Characterization of novel splice variants of LGR7 and LGR8 reveals that receptor signaling is mediated by their unique low density lipoprotein class A modules". J. Biol. Chem. 281 (46): 34942–54. doi:10.1074/jbc.M602728200. PMID 16963451.
  • El Houate B, Rouba H, Sibai H, et al. (2007). "Novel mutations involving the INSL3 gene associated with cryptorchidism". J. Urol. 177 (5): 1947–51. doi:10.1016/j.juro.2007.01.002. PMID 17437853.
  • Scott DJ, Wilkinson TN, Zhang S, et al. (2007). "Defining the LGR8 residues involved in binding insulin-like peptide 3". Mol. Endocrinol. 21 (7): 1699–712. doi:10.1210/me.2007-0097. PMID 17473281.

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.